Mineralys Therapeutics, Inc.

8-K Other events Jun 3, 2026 8-K Entered a material agreement; Took on a direct financial obligation Jun 3, 2026 8-K Shareholder vote results May 22, 2026 10-Q Quarter ended 2026-03-31 May 6, 2026 8-K Results of operations (earnings release) May 6, 2026 10-K Fiscal year ended 2025-12-31 Mar 12, 2026 8-K Results of operations (earnings release) Mar 12, 2026 8-K Regulation FD disclosure; Other events Mar 9, 2026 8-K Regulation FD disclosure; Other events Jan 6, 2026 10-Q Quarter ended 2025-09-30 Nov 10, 2025 8-K Results of operations (earnings release) Nov 10, 2025 8-K Other events Sep 3, 2025 8-K Other events Sep 2, 2025 10-Q Quarter ended 2025-06-30 Aug 12, 2025 8-K Results of operations (earnings release) Aug 12, 2025 8-K Regulation FD disclosure; Other events Jun 17, 2025 8-K Shareholder vote results May 22, 2025 10-Q Quarter ended 2025-03-31 May 12, 2025 8-K Results of operations (earnings release) May 12, 2025 8-K Regulation FD disclosure; Other events Mar 31, 2025 8-K Other events Mar 12, 2025 8-K Regulation FD disclosure; Other events Mar 10, 2025 10-K Fiscal year ended 2024-12-31 Feb 12, 2025 8-K Results of operations (earnings release) Feb 12, 2025 8-K Regulation FD disclosure; Other events Feb 4, 2025 8-K Regulation FD disclosure; Other events Jan 8, 2025 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Results of operations (earnings release) Nov 12, 2024 8-K Regulation FD disclosure; Other events Oct 30, 2024 8-K Regulation FD disclosure; Other events Sep 25, 2024 10-Q Quarter ended 2024-06-30 Aug 13, 2024 8-K Results of operations (earnings release) Aug 13, 2024 8-K Director or officer change Jun 14, 2024 8-K Other events Jun 10, 2024 8-K May 31, 2024 8-K Shareholder vote results May 22, 2024 10-Q Quarter ended 2024-03-31 May 9, 2024 8-K Results of operations (earnings release) May 9, 2024 8-K Director or officer change Apr 4, 2024 8-K Entered a material agreement; Results of operations (earnings release) Mar 21, 2024